You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Switch-maintenance

Showing 1 - 25 of 6,936
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Cairo, Egypt
    Ain Shams University Hospital
Dec 20, 2022

Metastatic Cancer, Urothelial Carcinoma Trial (avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin)

Not yet recruiting
  • Metastatic Cancer
  • Urothelial Carcinoma
  • avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin
  • (no location specified)
Dec 19, 2022

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Urothelial Carcinoma Trial in Irvine, Dallas, Houston (MRx0518, Avelumab 20 mg/mL Intravenous Solution (IV))

Active, not recruiting
  • Urothelial Carcinoma
  • MRx0518
  • Avelumab 20 mg/mL Intravenous Solution (IV)
  • Irvine, California
  • +2 more
Jul 5, 2022

Hiv Trial in France (Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO])

Not yet recruiting
  • Hiv
  • Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]
  • Caen, France
  • +3 more
Sep 6, 2023

Metastatic Non Small Cell Lung Cancer Trial in Nicosia (Pembrolizumab)

Unknown status
  • Metastatic Non Small Cell Lung Cancer
  • Nicosia, Strovolos, Cyprus
    Bank of Cyprus Oncology Centre
Jan 26, 2021

Squamous NSCLC Trial in Italy (Nivolumab 10 MG/ML Intravenous Solution, Best Supportive Care)

Active, not recruiting
  • Squamous Non-small Cell Lung Cancer
  • Nivolumab 10 MG/ML Intravenous Solution
  • Best Supportive Care
  • Imola, Bologna, Italy
  • +30 more
Sep 30, 2022

Covid19, Angiotensin II Receptor Antagonist Adverse Reaction Trial in São Paulo (Renin-angiotensin system inhibitors)

Terminated
  • Covid19
  • Angiotensin II Receptor Antagonist Adverse Reaction
  • Renin-angiotensin system inhibitors
  • São Paulo, SP, Brazil
    Instituto do Coração - Incor HCFMUSP
Sep 28, 2021

HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

Not yet recruiting
  • HIV Infections
  • (no location specified)
Jun 13, 2023

Depression Trial in San Francisco (Augment w/mHealth, Maintenance, Switch to CBT & mHealth)

Completed
  • Depression
  • Augment w/mHealth
  • +3 more
  • San Francisco, California
    Ward 86 HIV Clinic, Zuckerberg San Francisco General Hospital
Aug 29, 2022

HIV, AIDS, Virologic Failure Trial (Maintenance on TLD treatment strategy, Individualized Care treatment strategy, Immediate

Not yet recruiting
  • HIV Infections
  • +2 more
  • Maintenance on TLD treatment strategy
  • +2 more
  • (no location specified)
May 9, 2022

Acute Heart Failure, Diuretics Drug Reactions Trial in Jette, Hasselt (diagnostic test, drug, other)

Recruiting
  • Acute Heart Failure
  • Diuretics Drug Reactions
  • UNa measurement after intravenous loop diuretic bolus
  • +9 more
  • Jette, Brussels, Belgium
  • +1 more
Jun 12, 2022

IBD, Crohn Disease, Ulcerative Colitis Trial (Infliximab)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • (no location specified)
Oct 27, 2023

Non ST Segment Elevation Acute Coronary Syndrome, Non-ST-Segment Elevation Myocardial Infarction (NSTEMI), Unstable Angina Trial

Not yet recruiting
  • Non ST Segment Elevation Acute Coronary Syndrome
  • +2 more
  • De-escalation to ticagrelor 60 mg at day 30
  • +3 more
  • Bydgoszcz, Kujawsko-pomorskie, Poland
    Department of Cardiology, Dr. A. Jurasz University Hospital, Col
Mar 9, 2023

Long-acting Injectable Cabotegravir + Rilpivirine

Not yet recruiting
  • Patient Satisfaction
  • +3 more
    • Santiago, Region Metropolitana, Chile
      CICUC
    Apr 18, 2023

    Metastatic Colorectal Cancer Trial in Munich (Bevacizumab, Irinotecan, Folinic acid)

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Munich, Germany
      Klinikum der Universitaet Muenchen
    Dec 2, 2021

    Pancreas Cancer Trial in United States (TG01 Vaccine, QS-21, Balstilimab)

    Recruiting
    • Pancreas Cancer
    • TG01 Vaccine
    • +2 more
    • Fairway, Kansas
    • +4 more
    Jan 30, 2023

    EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM

    Recruiting
    • Inflammatory Bowel Diseases
    • Rheumatologic Disease
    • Milano, Italy
      Irccs Ospedale San Raffaele
    Jan 30, 2023

    Ulcerative Colitis or Crohn's Disease Receiving Vedolizumab in

    Recruiting
    • Inflammatory Bowel Disease (IBD)
    • +2 more
      • Wroclaw, Dolnoslskie, Poland
      • +10 more
      Sep 12, 2022

      Bone Sarcoma, Osteosarcoma Trial in France (Treatment by regorafenib and best supportive care, Treatment by and best supportive

      Recruiting
      • Bone Sarcoma
      • Osteosarcoma
      • Treatment by regorafenib and best supportive care
      • Treatment by placebo and best supportive care
      • Besançon, France
      • +13 more
      May 12, 2022

      HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

      Active, not recruiting
      Has Results
      • HIV Infections
      • DTG 50 mg
      • +2 more
      • Long Beach, California
      • +64 more
      Dec 3, 2021

      HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

      Active, not recruiting
      Has Results
      • HIV Infections
      • DTG 50 mg
      • +2 more
      • Bakersfield, California
      • +61 more
      Dec 3, 2021

      HIV-1-infection Trial in Kenya (Dolutegravir)

      Completed
      • HIV-1-infection
      • Kiambu, Kenya
      • +3 more
      Jan 26, 2022

      Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK744, GSK744 LA, TMC278 LA)

      Active, not recruiting
      Has Results
      • Infection, Human Immunodeficiency Virus
      • HIV Infections
      • Birmingham, Alabama
      • +49 more
      Dec 26, 2022

      HIV Trial (DTG/3TC)

      Not yet recruiting
      • HIV
      • (no location specified)
      Jun 9, 2023